Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Sarah Avent

- PMLiVE

NICE says no to Novartis’ Kisqali combo in breast cancer

Double blow after Lilly rival recommended

- PMLiVE

PMEA names Dr Paul Stuart-Kregor as Chair of Judges

He succeeds Professor Brian Smith

The Orkambi row explained

Q&A and timeline

The playbook of a ‘reluctant creative’

Are we all capable of being creative?

Bedrock Healthcare Communications

- PMLiVE

Lynparza set for further expansion with EU approval in breast cancer

Companies have prostate cancer and pancreatic cancer in their sights

- PMLiVE

Brexit causing ‘significant’ generic drug shortages

Generics firms contest reason for shortages

- PMLiVE

EU files WTO dispute with Turkey over pharma laws

Country breaks WTO obligations

- PMLiVE

Tit for tat as PBMs blame pharma for high drug prices

US Senate turns its spotlight on 'middlemen'

- PMLiVE

Amgen and UCB’s Evenity finally approved, but with label warnings

Drug unlikely to match Prolia's revenues

- PMLiVE

The Orkambi blame game

Grilling by MPs sheds some light on long-running row over CF drug

Clinical Trial Materials: Getting the basics right

Clinical Trials Materials: Getting the Basics Right

For those unfamiliar with them, clinical trials can be rather bewildering. This presents problems when it comes to recruiting patients — how can we make sure they understand what they...

Cuttsy + Cuttsy

News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.Read more about this report here

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links